Hemispherx Biopharma News
Most Popular Hemispherx Biopharma Story
Hemispherx offers more data on Ampligen
Hoping to overcome the FDA's concerns regarding Ampligen, Hemispherx announced that it has submitted new preclinical data for the drug to regulators. The agency had rejected Ampligen after concluding Read more...
Latest Headlines
- August 20, 2010
- January 15, 2010
- December 2, 2009
- July 23, 2009
- February 20, 2009
- December 1, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
